These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2476267)

  • 1. Aprotinin inhibition of experimental pemphigus in Balb-c mice following passive transfer of pemphigus foliaceus serum.
    Spillman DH; Magnin PH; Roquel L; Mitsui M
    Clin Exp Dermatol; 1988 Sep; 13(5):321-7. PubMed ID: 2476267
    [No Abstract]   [Full Text] [Related]  

  • 2. Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer.
    Roscoe JT; Diaz L; Sampaio SA; Castro RM; Labib RS; Takahashi Y; Patel H; Anhalt GJ
    J Invest Dermatol; 1985 Dec; 85(6):538-41. PubMed ID: 3905977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of kallikrein and plasmin inhibition capacity by aprotinin using a new assay to monitor therapy.
    Gallimore MJ; Fuhrer G; Heller W; Hoffmeister HE
    Adv Exp Med Biol; 1989; 247B():55-60. PubMed ID: 2481953
    [No Abstract]   [Full Text] [Related]  

  • 4. [The identification of inhibitors of acantholysis of pemphigus vulgaris].
    Naito K
    Nihon Hifuka Gakkai Zasshi; 1987 Oct; 97(11):1231-8. PubMed ID: 2965270
    [No Abstract]   [Full Text] [Related]  

  • 5. Textilinin-1, an alternative anti-bleeding agent to aprotinin: Importance of plasmin inhibition in controlling blood loss.
    Flight SM; Johnson LA; Du QS; Warner RL; Trabi M; Gaffney PJ; Lavin MF; de Jersey J; Masci PP
    Br J Haematol; 2009 Apr; 145(2):207-11. PubMed ID: 19236611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus.
    Vu TN; Lee TX; Ndoye A; Shultz LD; Pittelkow MR; Dahl MV; Lynch PJ; Grando SA
    Arch Dermatol; 1998 Aug; 134(8):971-80. PubMed ID: 9722727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The plant lectin wheat germ agglutinin inhibits the binding of pemphigus foliaceus autoantibodies to desmoglein 1 in a majority of patients and prevents pathomechanisms of pemphigus foliaceus in vitro and in vivo.
    Ortiz-Urda S; Elbe-Bürger A; Smolle J; Marquart Y; Chudnovsky Y; Ridky TW; Bernstein P; Wolff K; Rappersberger K
    J Immunol; 2003 Dec; 171(11):6244-50. PubMed ID: 14634141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of acantholysis in pemphigus foliaceus.
    España A; Diaz LA; Mascaró JM; Giudice GJ; Fairley JA; Till GO; Liu Z
    Clin Immunol Immunopathol; 1997 Oct; 85(1):83-9. PubMed ID: 9325073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Trasylol for pancreatitis.
    Haberland GL
    Br Med J; 1974 Nov; 4(5942):469. PubMed ID: 4279129
    [No Abstract]   [Full Text] [Related]  

  • 10. Desmocollins I and II are recognized by certain sera from patients with various types of pemphigus, particularly Brazilian pemphigus foliaceus.
    Dmochowski M; Hashimoto T; Garrod DR; Nishikawa T
    J Invest Dermatol; 1993 Apr; 100(4):380-4. PubMed ID: 8454900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aprotinin: mechanism of action and therapeutical uses.
    Fussi F
    Boll Chim Farm; 1980 Nov; 119(11):631-46. PubMed ID: 6164378
    [No Abstract]   [Full Text] [Related]  

  • 12. Clearance efficacy of autoantibodies in double filtration plasmapheresis for pemphigus foliaceus.
    Kasuya A; Moriki M; Tatsuno K; Hirakawa S; Tokura Y
    Acta Derm Venereol; 2013 Mar; 93(2):181-2. PubMed ID: 22948906
    [No Abstract]   [Full Text] [Related]  

  • 13. [Uliron therapy of pemphigus; hematic changes in pemphigus foliaceus after administration of uliron].
    HAENSCH R
    Z Haut Geschlechtskr; 1951 Dec; 11(11):482-7. PubMed ID: 14922919
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of antiplasmin preparations and heparin on experimentally induced intravascular coagulation (author's transl)].
    Maki M; Nagayama M; Oda T
    Rinsho Ketsueki; 1974 Feb; 15(2):184-90. PubMed ID: 4276896
    [No Abstract]   [Full Text] [Related]  

  • 15. [The results of phylogenetic and experimental research into the etiology of pemphigus vulgaris].
    Grando SS; Glukhen'kiĭ BT; Sokolov OA; Kravchenko RS; Gavrilov SV
    Vestn Dermatol Venerol; 1989; (4):7-9. PubMed ID: 2669411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Jamarsan therapy of pemphigus foliaceus; reversal to a form of Senear-Usher syndrome].
    ORSINI O; MARIANO J
    Rev Bras Med; 1952 May; 9(5):301. PubMed ID: 13047804
    [No Abstract]   [Full Text] [Related]  

  • 17. The extracellular aminoterminal domain of bovine desmoglein 1 (Dsg1) is recognized only by certain pemphigus foliaceus sera, whereas its intracellular domain is recognized by both pemphigus vulgaris and pemphigus foliaceus sera.
    Dmochowski M; Hashimoto T; Amagai M; Kudoh J; Shimizu N; Koch PJ; Franke WW; Nishikawa T
    J Invest Dermatol; 1994 Aug; 103(2):173-7. PubMed ID: 8040606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin.
    Ray MJ; Marsh NA
    Thromb Haemost; 1997 Sep; 78(3):1021-6. PubMed ID: 9308747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity and epitope characteristics of anti-desmoglein-1 from pemphigus foliaceus patients expressing only IgG1 autoantibodies.
    Hacker-Foegen MK; Janson M; Amagai M; Fairley JA; Lin MS
    J Invest Dermatol; 2003 Dec; 121(6):1373-8. PubMed ID: 14675185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution, half life time and placental transfer of the protease inhibitor trasylol.
    Beller FK; Epstein MD; Kaller H
    Thromb Diath Haemorrh; 1966 Jul; 16(1):302-10. PubMed ID: 4229627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.